CYduct Diagnostics Inc (CYDX)

[mgrego]

A/S 851M shares with just about 100M before being maxed. Highly unlikely the company increases A/S before a major milestone (CE Mark).

SNDY Current MC $1.702M. Obviously way undervalued even with the current S/S. SNDY BV $2.15M

I didn't particular like 190M new shares to hit the market (it reduces expected ROI) but it was as transparent as it comes. It hasn't been hard (at all) to track where the dilution is coming from, Preferred shares (that have been issued to Boost) are being converted to common shares. It's funny how nobody is talking about how all these shares have been absorbed at or above the 52 week low ahead of the CE Mark. $0.002 continues to be strong support.

The company has been able to continue carrying very little debt (Current Liabilities ~$173K). Solos has been able to keep its balance sheet very healthy despite how long the ISO process has taken. Costs associated with the CE Mark are finished, the company has the opportunity to reach quarterly profitability by increasing revenue a few hundred K.

Also important

Authorized Preferred Shares: 20M shares with only 650K outstanding.

No reason to authorize so many Preferred Shares if you don't expect to use them to generate capital.

A/S will likely increase at some point but the question is by how much. The CE Mark is a huge deal for a small medical device company looking to form a partnership or exit via M&A. CE Mark combined with international distribution would lead to a significantly higher PPS.

GLTA